HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The role of polyunsaturated ω-3 fatty acid eicosapentaenoic acid-derived resolvin E1 (RvE1) in bone preservation.

Abstract
Resolvin E1 (RvE1) is a recently discovered lipid-derived mediator that is endogenously synthesized from the polyunsaturated fatty acid eicosapentaenoic acid. RvE1 is locally generated in response to inflammation where it enhances the resolution phase of inflammation by diminishing neutrophil chemotaxis and by enhancing nonphlogistic macrophage-directed clearance of apoptotic neutrophils. RvE1 was also found to be effective in preventing and restoring bone loss in the inflammatory bone disease periodontitis. This review examines experimental evidence on RvEl's actions in bone. Current data indicate that in addition to anti-inflammatory actions, RvE1 also directly acts on bone cells and promotes bone preservation.
AuthorsRobert Gyurko, Thomas E Van Dyke
JournalCritical reviews in immunology (Crit Rev Immunol) Vol. 34 Issue 4 Pg. 347-57 ( 2014) ISSN: 1040-8401 [Print] United States
PMID24941160 (Publication Type: Journal Article, Review)
Chemical References
  • Eicosapentaenoic Acid
  • 5S,12R,18R-trihydroxy-6Z,8E,10E,14Z,16E-eicosapentaenoic acid
Topics
  • Animals
  • Bone Remodeling
  • Bone Resorption
  • Bone and Bones (metabolism, pathology)
  • Eicosapentaenoic Acid (analogs & derivatives, metabolism)
  • Humans
  • Inflammation (metabolism, pathology)
  • Lipid Metabolism

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: